Ebola’s Impact on the Eyes: Ophthalmology Times

by MedPage Today • 2017/07/05 • 0 Comments

(MedPage Today) -- Also, questionable phase III AMD treatment trial forges ahead

← Study deems loteprednol etabonate clinically noninferior to prednisolone/fluorometholone

HxRefactored 2017 Day 2: Healthcare Policy, a Deep Dive into Blockchain, and Yoga →